AR050542A1 - IMIDAZOPIRIDINE COMPOUNDS PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents

IMIDAZOPIRIDINE COMPOUNDS PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Info

Publication number
AR050542A1
AR050542A1 ARP050103619A ARP050103619A AR050542A1 AR 050542 A1 AR050542 A1 AR 050542A1 AR P050103619 A ARP050103619 A AR P050103619A AR P050103619 A ARP050103619 A AR P050103619A AR 050542 A1 AR050542 A1 AR 050542A1
Authority
AR
Argentina
Prior art keywords
group
branched
linear
aryl
alkyl
Prior art date
Application number
ARP050103619A
Other languages
Spanish (es)
Inventor
Gerald Guillaumet
Sabine Berteine-Raboin
Kazzouli Said El
Philippe Delagrange
Daniel-Henri Caignard
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of AR050542A1 publication Critical patent/AR050542A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Reivindicacion 1: Compuestos de formula 1 en la cual A representa un grupo -NHCOR1 o -CONHR1, donde R1 representa un grupo alquilo (C1-6) lineal o ramificado, un grupo cicloalquilo (C3-8), un grupo cicloalquil (C3-8) alquilo (C1-6) donde la parte alquilo puede ser lineal o ramificada, un grupo arilo, un grupo arilalquilo (C1-6) donde la parte alquilo puede ser lineal o ramificada, un grupo heteroarilo o un grupo heteroarilalquilo (C1-6) donde la parte alquilo puede ser lineal o ramificada, R2 representa un grupo alcoxi (C1-6) lineal o ramificado, R3 representa un grupo arilo, un grupo arilalquilo (C1-6) donde la parte alquilo puede ser lineal o ramificada, o un grupo aroilo y se entiende que: el término ''arilo'' significa un grupo fenilo, naftilo obifenilo, el término ''aroilo'' significa un grupo C(=O)-arilo, donde ''arilo'' es tal como se ha definido anteriormente, el término ''heteroarilo'' significa cualquier grupo aromático mono- o bicíclico que contiene entre 1 a 3 heteroátomos seleccionados entre oxígeno, azufre y nitrogeno, y es posible substituir los grupos arilo, aroilo y heteroarilo definidos por 1 a 3 grupos seleccionados entre alquilo (C1-6) lineal o ramificado, alcoxi (C1-6) lineal o ramificado, hidroxi, carboxi, formilo, nitro, ciano, polihaloalquilo (C1-6) lineal o ramificado, alquiloxicarbonilo y átomos de halogeno, sus enantiomeros y diasteroisomeros, así como también sus sales de adicion con un ácido o una base farmacéuticamente aceptableClaim 1: Compounds of formula 1 in which A represents a -NHCOR1 or -CONHR1 group, wherein R1 represents a linear or branched (C1-6) alkyl group, a (C3-8) cycloalkyl group, a (C3-) cycloalkyl group 8) (C1-6) alkyl where the alkyl part can be linear or branched, an aryl group, an arylalkyl (C1-6) group where the alkyl part can be linear or branched, a heteroaryl group or a heteroarylalkyl (C1- 6) where the alkyl part can be linear or branched, R2 represents a linear or branched (C1-6) alkoxy group, R3 represents an aryl group, an aryl (C1-6) alkyl group where the alkyl part can be linear or branched, or an aroyl group and it is understood that: the term "aryl" means a phenyl, naphthyl obiphenyl group, the term "aroyl" means a C (= O) -aryl group, where "aryl" is such as defined above, the term "heteroaryl" means any mono- or bicyclic aromatic group containing between 1 to 3 heteroá volumes selected from oxygen, sulfur and nitrogen, and it is possible to replace the defined aryl, aroyl and heteroaryl groups with 1 to 3 groups selected from linear or branched (C1-6) alkyl, linear or branched (C1-6) alkoxy, hydroxy, carboxy, formyl, nitro, cyano, linear or branched (C1-6) polyhaloalkyl, alkyloxycarbonyl and halogen atoms, their enantiomers and diasteroisomers, as well as their addition salts with a pharmaceutically acceptable acid or base

ARP050103619A 2004-08-31 2005-08-30 IMIDAZOPIRIDINE COMPOUNDS PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AR050542A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0409202A FR2874611B1 (en) 2004-08-31 2004-08-31 NOVEL IMIDAZOPYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Publications (1)

Publication Number Publication Date
AR050542A1 true AR050542A1 (en) 2006-11-01

Family

ID=34947773

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050103619A AR050542A1 (en) 2004-08-31 2005-08-30 IMIDAZOPIRIDINE COMPOUNDS PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Country Status (3)

Country Link
AR (1) AR050542A1 (en)
FR (1) FR2874611B1 (en)
WO (1) WO2006027474A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5160764B2 (en) * 2006-10-13 2013-03-13 全薬工業株式会社 Antidepressant, brain protectant, amyloid β deposition inhibitor or aging inhibitor containing a heterocyclic compound having a specific structure
JP5227806B2 (en) 2006-12-08 2013-07-03 武田薬品工業株式会社 Tricyclic compounds and their pharmaceutical uses
CA2963784A1 (en) 2007-06-08 2008-12-18 Mannkind Corporation Ire-1.alpha. inhibitors
EP2072516A1 (en) * 2007-12-21 2009-06-24 Santhera Pharmaceuticals (Schweiz) AG Substituted imidazopyridine derivates as Melancortin-4 receptor antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492382A1 (en) * 1980-10-22 1982-04-23 Synthelabo IMIDAZO (1,2-A) PYRIDINE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
FR2525601A1 (en) * 1982-04-21 1983-10-28 Synthelabo IMIDAZO (1,2-A) PYRIDINE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
FR2568880B1 (en) * 1984-08-07 1986-12-12 Synthelabo IMIDAZO ACYLAMINOMETHYL-3 DERIVATIVES (1,2-A) PYRIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
EP0375726A4 (en) * 1987-08-17 1991-01-30 Whitby Research Incorporated Melatonin analogues
FR2680366B1 (en) * 1991-08-13 1995-01-20 Adir NOVEL ARYLETHYLAMINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
SE0100568D0 (en) * 2001-02-20 2001-02-20 Astrazeneca Ab Compounds

Also Published As

Publication number Publication date
FR2874611B1 (en) 2006-11-17
FR2874611A1 (en) 2006-03-03
WO2006027474A2 (en) 2006-03-16
WO2006027474A3 (en) 2006-06-08

Similar Documents

Publication Publication Date Title
AR061739A1 (en) NEW NAFTALENIC DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HUP0401784A2 (en) Viral polymerase inhibitors with a heterobicyclic structure, process for their preparation, their intermediates and pharmaceutical compositions containing them
AR059957A1 (en) DERIVATIVES OF SPIROINDOLINONE, METHODS FOR THEIR PREPARATION, A PHARMACEUTICAL COMPOSITION CONTAINING THEM AND THEIR USE IN THE MANUFACTURE OF MEDICINES FOR THE TREATMENT OF CANCER.
CO6290658A2 (en) DERIVATIVES OF AZETIDINE AND CYCLLOBUTANE AS JACK INHIBITORS
ES2590504T3 (en) N-cyclolamides as nematicides
PE20021088A1 (en) AMIDES OF ANTRANILIC ACIDS, PROCEDURE FOR THEIR PREPARATION AS WELL AS PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM
AR076435A1 (en) COMPOUNDS OF REPLACED INDAZOLS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PROCESSES TO OBTAIN THEMSELVES
AR057071A1 (en) COMBINATION PRODUCT INCLUDING SUBSTITUTED ARILPIRAZOLES
ES2328820T3 (en) DERIVATIVES OF 4- (PIRAZOL-3-ILAMINO) PYRIMIDINE FOR USE IN CANCER TREATMENT.
AR048641A1 (en) ARTH- OR HETEROARILAMIDE ORTHOSUSTITUTED COMPOUNDS USEFUL AS ANTAGO-NISTAS OF THE PROSTAGLANDINAS E2 RECEIVER; PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE IN THE MANUFACTURE OF A MEDICAME
AR062677A1 (en) DERIVATIVES OF BIARIL-SULFONAMIDE, PRODUCTION PROCESSES AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM
NO20076006L (en) acetylene Derivatives
AR053554A1 (en) PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS
AR061835A1 (en) TETRACICLIC DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NI200800015A (en) DERIVATIVES OF N- (HETEROARYL) -1-HETEROARYLALKYL - 1H - INDOL - 2 - CARBOXAMIDES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS.
CO5601021A2 (en) DERIVATIVES OF QUINAZOLINONA, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR PREPARATION PROCESS AND ITS USE AS ANTAGONISTS CB
AR041883A1 (en) PIRIDOPIRIMIDINONE COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR084515A1 (en) NITROGEN HETEROCICLICAL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME IN THE TREATMENT OF DISEASES ASSOCIATED WITH THE CENTRAL NERVOUS SYSTEM SUCH AS PARKINSON AND ALZHEIMER, BETWEEN OTHER
AR041882A1 (en) IMIDAZOPIRIDINE COMPOUNDS, A PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR042362A1 (en) DERIVATIVES OF 3H-QUINAZOLIN-4-ONA, PROCESS OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR066603A1 (en) DERIVATIVES OF ARILAMIDA PIRIMIDONA
AR071217A1 (en) BENCIMIDAZOL DERIVATIVES
AR050542A1 (en) IMIDAZOPIRIDINE COMPOUNDS PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR054121A1 (en) PHENYL PIRIDYL PIPERAZINE COMPOUNDS, PREPARATION PROCEDURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PHARMACOLOGICAL USES AS ANTAGONIST OF HISTAMINERGIC RECEPTORS H3
AR050032A1 (en) DERIVATIVES OF BENZOIC ACID AS NON-NUCLEOSID INHIBITORS OF THE REVERSE TRANSCRIPT

Legal Events

Date Code Title Description
FB Suspension of granting procedure